Biotech Firm Gilead Hammered

Gilead Sciences shares are getting hammered today after disappointing test results on one of its Hepatitis C drugs, with CNBC's Seema Mody

CNBC | February 17, 2012

Tags:. .seema. .gilead. .mody. .biotech. .hepatitis